A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes

Clinical trial NCT05693909 · RECRUITING

Trial details

NCT number: NCT05693909
Sponsor: Pharmacosmos A/S
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Beta Thalassemia Major Anemia Myelodysplastic Syndrome

Start date: 2023-09-04
Primary completion: 2027-10-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.